kelokely@uwyo.edu
B.Sc., Pharmaceutical Sciences, Tanta University
M.Sc., Pharmaceutical Analysis, Tanta University
Ph.D., Medicinal Chemistry, The University of Mississippi
Postdoctoral, Drug Discovery, Temple University
Dr. Khaled Elokely specializes in the integration of computational and medicinal chemistry for innovative drug design and development at the University of Wyoming. With a background in pharmaceutical sciences and a Ph.D. from the University of Mississippi, Dr. Elokley's expertise extends to quality control and assurance of active pharmaceutical ingredients (APIs), adding a valuable dimension to his research and teaching.
Dr. Elokely's research program focuses on unraveling the complexities of drug recognition at the molecular level. His work employs cutting-edge computational techniques alongside modern medicinal chemistry approaches, including AI-integrated drug discovery, structure-based design, and advanced synthetic methodologies. Current research projects span a wide range of critical areas, including the development of novel therapeutic approaches for neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, development of selective opioid modulators, conception of computational frameworks for natural product analysis, and exploration of novel targets in cancer treatment.
As an educator, Dr. Elokely brings his extensive experience to the classroom, teaching Medicinal Chemistry and Drug Design courses. He is committed to fostering the next generation of scientists, guiding students in developing and executing impactful research projects. His work is supported by various grants and academic partnerships. Through his integrated approach to computational and medicinal chemistry, coupled with his background in API quality assurance, Dr. Elokely continues to contribute to the advancement of drug discovery and development, aiming to address complex medical conditions with more effective and targeted therapeutics.